Investigating the nature of the secondary binding site of the human β1-adrenoceptor using fluorescent ligands and confocal microscopy

CGP 12177 is a high affinity β-blocker that antagonises agonist responses mediated through the catecholamine binding site of the human β1-adrenoceptor (β1AR). However, CGP 12177 also exerts agonist activity through a secondary, low affinity “CGP 12177” binding site/conformational state of the β1AR....

Full description

Bibliographic Details
Main Author: Gherbi, Karolina
Format: Thesis (University of Nottingham only)
Language:English
Published: 2013
Online Access:https://eprints.nottingham.ac.uk/13426/
_version_ 1848791731465617408
author Gherbi, Karolina
author_facet Gherbi, Karolina
author_sort Gherbi, Karolina
building Nottingham Research Data Repository
collection Online Access
description CGP 12177 is a high affinity β-blocker that antagonises agonist responses mediated through the catecholamine binding site of the human β1-adrenoceptor (β1AR). However, CGP 12177 also exerts agonist activity through a secondary, low affinity “CGP 12177” binding site/conformational state of the β1AR. In this thesis, we aimed to further our understanding of the nature of the secondary “CGP 12177” site by investigating ligand-receptor interactions at this site at the single cell level, using fluorescent derivatives of CGP 12177 (BODIPY-TMR-CGP, BY-CGP) and propranolol (BODIPY630/650-S-PEG8-propranolol, BY-PROP) in confocal microscopy studies. Initial studies demonstrated that both fluorescent β-adrenoceptor ligands displayed similar pharmacology at the human β1AR to their respective parent compounds, and that both ligands allowed visualisation of β1AR expressed in CHO cells. Using BY-CGP in a live cell fluorescence-based automated screening assay revealed two-phase antagonist displacement binding curves. In subsequent kinetic binding studies performed on a confocal perfusion system, we used infinite dilution conditions to determine dissociation rates of BY-CGP in the absence and presence of unlabelled ligands at the single cell level. BY-CGP dissociation rates were enhanced in the presence of unlabelled ligands, thus highlighting an allosteric mechanism of action of CGP 12177 at the human β1AR. Preliminary data using bimolecular fluorescence complementation suggested that these co-operative interactions between the two β1-adrenoceptor binding sites were mediated across a β1-adrenoceptor homodimer interface.
first_indexed 2025-11-14T18:33:10Z
format Thesis (University of Nottingham only)
id nottingham-13426
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T18:33:10Z
publishDate 2013
recordtype eprints
repository_type Digital Repository
spelling nottingham-134262025-02-28T11:25:08Z https://eprints.nottingham.ac.uk/13426/ Investigating the nature of the secondary binding site of the human β1-adrenoceptor using fluorescent ligands and confocal microscopy Gherbi, Karolina CGP 12177 is a high affinity β-blocker that antagonises agonist responses mediated through the catecholamine binding site of the human β1-adrenoceptor (β1AR). However, CGP 12177 also exerts agonist activity through a secondary, low affinity “CGP 12177” binding site/conformational state of the β1AR. In this thesis, we aimed to further our understanding of the nature of the secondary “CGP 12177” site by investigating ligand-receptor interactions at this site at the single cell level, using fluorescent derivatives of CGP 12177 (BODIPY-TMR-CGP, BY-CGP) and propranolol (BODIPY630/650-S-PEG8-propranolol, BY-PROP) in confocal microscopy studies. Initial studies demonstrated that both fluorescent β-adrenoceptor ligands displayed similar pharmacology at the human β1AR to their respective parent compounds, and that both ligands allowed visualisation of β1AR expressed in CHO cells. Using BY-CGP in a live cell fluorescence-based automated screening assay revealed two-phase antagonist displacement binding curves. In subsequent kinetic binding studies performed on a confocal perfusion system, we used infinite dilution conditions to determine dissociation rates of BY-CGP in the absence and presence of unlabelled ligands at the single cell level. BY-CGP dissociation rates were enhanced in the presence of unlabelled ligands, thus highlighting an allosteric mechanism of action of CGP 12177 at the human β1AR. Preliminary data using bimolecular fluorescence complementation suggested that these co-operative interactions between the two β1-adrenoceptor binding sites were mediated across a β1-adrenoceptor homodimer interface. 2013-07-11 Thesis (University of Nottingham only) NonPeerReviewed application/pdf en arr https://eprints.nottingham.ac.uk/13426/1/Karolina.Gherbi_thesis_201307.pdf Gherbi, Karolina (2013) Investigating the nature of the secondary binding site of the human β1-adrenoceptor using fluorescent ligands and confocal microscopy. PhD thesis, University of Nottingham.
spellingShingle Gherbi, Karolina
Investigating the nature of the secondary binding site of the human β1-adrenoceptor using fluorescent ligands and confocal microscopy
title Investigating the nature of the secondary binding site of the human β1-adrenoceptor using fluorescent ligands and confocal microscopy
title_full Investigating the nature of the secondary binding site of the human β1-adrenoceptor using fluorescent ligands and confocal microscopy
title_fullStr Investigating the nature of the secondary binding site of the human β1-adrenoceptor using fluorescent ligands and confocal microscopy
title_full_unstemmed Investigating the nature of the secondary binding site of the human β1-adrenoceptor using fluorescent ligands and confocal microscopy
title_short Investigating the nature of the secondary binding site of the human β1-adrenoceptor using fluorescent ligands and confocal microscopy
title_sort investigating the nature of the secondary binding site of the human β1-adrenoceptor using fluorescent ligands and confocal microscopy
url https://eprints.nottingham.ac.uk/13426/